Replies to post #53431 on Innovation Pharmaceuticals Inc (IPIX)

[ridinbulls]

The only reason I would disagree I because CTIX had the current valuations prior to obtaining Poly assets. It depends on if it is a clinically significant difference too. There is a unique advantage to single dose therapy over 7 day. I believe that holds value and based off of phase IIa I think it's more of a 70/30 pro brilacidin. That's IMO of course